LETTERS TO THE EDITOR
Tests for growth hormone secretion SIR,-We were interested in the correspondence between Dr Addy and Professor Brook and Dr Hindmarsh on detecting organic illness through assessment of height velocity.' 2 The question, however, is academic and their arguments theoretical since, as we have recently shown, the assessment of height velocity in individuals is so imprecise as to be clinically meaningless. There is effectively no correlation between successive velocities, so that a 12 month velocity cannot possibly identify anyone.3'4
The Wessex Growth Study provides a practical demonstration of the problem. Thirty (17%) of the original cohort of 174 school entrants below the third height centile had identifiable organic disease. Eighteen of these were monitored over a period of three years alongside a cohort of 78 short 'normal' children in whom all pathology had been excluded. The height velocity of four of the short 'normal' children and two of those with organic disease was deemed to be on or below the third centile for velocity after the first year. Over the next 12 months, two of the short 'normal' subjects, and three of those with organic disease, were growing at a rate below the third centile, but the identity of the 'poor growers' changed from year one to year two. We should abandon the notion that low 12 month velocities will effectively identify pathology. The children in the Wessex Growth Study with organic causes of short stature were identified at the beginning of year one on the basis of height screening alone. Professor Healy is right to stress that velocity could, in some cases, be a useful discriminator in a screening context, but in our paper we were concerned mainly with the estimation of height velocities, and we showed that the imprecision attached to these estimations can beconsiderable. Unfortunately, diseasespecific growth charts are rare and more are needed.
In the' case of Turner's syndrome such a chart is available and the mean velocity is shown to be lower than normal. ' 2 If one were to screen for the disease by identifying all girls with a velocity less than the 3rd centile on the normal velocity chart, between the ages of 5-6 years, this would locate about 25% of girls with Turner's syndrome. On the other hand, screening for those below the 3rd centile for height, using the normal height chart at age 5 years, would pick out over 50% of these girls. (Actually, screening by height and then by velocity would be even better as girls with
Turner's syndrome are on average shorter than normal and they also fall further behind with increasing age. As Professor Healy points out, however, the extra information gained may not be worth the delay involved.) Terbutaline powder in asthma
